Aquagenic Pruritus

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-12-03
Clinical Trial Update: Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms [Phase 3]
A Phase 3 randomized trial comparing aprepitant to hydroxyzine in persistent aquagenic pruritus for patients with myeloproliferative neoplas…